(19)
(11) EP 0 906 423 A1

(12)

(43) Date of publication:
07.04.1999 Bulletin 1999/14

(21) Application number: 97921662.0

(22) Date of filing: 18.04.1997
(51) International Patent Classification (IPC): 
C07K 14/ 47( . )
C12N 15/ 12( . )
A61K 38/ 00( . )
C07K 16/ 30( . )
G01N 33/ 574( . )
(86) International application number:
PCT/EP1997/001963
(87) International publication number:
WO 1997/041221 (06.11.1997 Gazette 1997/47)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
RO SI

(30) Priority: 29.04.1996 US 19960016487P
28.02.1997 GB 19970004161

(71) Applicant: Novartis AG
4058 Basel (CH)

(72) Inventors:
  • BACHMANN, Felix
    CH-4052 Basel (CH)
  • BURGER, Max M.
    CH-4103 Bottmingen (CH)

(74) Representative: Becker, Konrad, et al 
Novartis AG Patent- und Markenabteilung CH Lichtstrasse 35
4002 Basel
4002 Basel (CH)

   


(54) METASTASIS-ASSOCIATED ANTIGEN AND ANTIBODIES THERETO